End Stage Renal Disease – Treatment Options: Dialysis Versus Transplant

  • Sandesh ParajuliEmail author
  • Patrick K. Reville


Treatment option for patients with end stage renal disease (ESRD) include dialysis and kidney transplantation. Patients with ESRD are at an increased risk for cardiovascular events, mortality and hospitalization. Kidney transplantation is considered to be the preferred method of treatment for patients with ESRD. With all treatment options there are desired and undesired effects. Compared to ESRD a patient after kidney transplantation lives longer, has better quality of life and incurs fewer costs. Also, certain parameters of chronic kidney disease (CKD) are better managed, or even halted, after Kidney transplantation include anemia, calcium phosphorus metabolism, and vascular calcification and undesired effects of Kidney transplantation include increased risk of infections, malignancy, fractures, obesity. Although mortality is significantly improved after kidney transplantation compared to dialysis but still transplant recipients carry 2–3 times higher mortality risk than general population. When comparing CKD with CKD after transplantation, rate of decline of estimated glomerular filtration rate was significantly lower in CKD after transplantation. However, they still could not benefit from long term allograft survival due to increased risk of mortality. Kidney transplant recipients are a unique subset of patients with multiple traditional risk factors as well as risk factors related to the transplant. Proper management and appropriate preventive health measures may improve long term patient and allograft survival.


End-stage renal disease Dialysis Transplantation Cost Anemia Mortality 


  1. 1.
    KDOQI, National Kidney F. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis. 2006;47(5 Suppl 3):S11–145.Google Scholar
  2. 2.
    Tsagalis G. Renal anemia: a nephrologist’s view. Hippokratia. 2011;15(Suppl 1):39–43.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Babitt JL, Lin HY. Mechanisms of anemia in CKD. J Am Soc Nephrol (JASN). 2012;23(10):1631–4.CrossRefGoogle Scholar
  4. 4.
    Slotki I. Intravenous iron supplementation in the anaemia of renal and cardiac failure–a double-edged sword? Nephrol Dial Transplant. 2005;20(Suppl 7):vii16–23.CrossRefGoogle Scholar
  5. 5.
    Swaminathan S, Mor V, Mehrotra R, Trivedi A. Medicare's payment strategy for end-stage renal disease now embraces bundled payment and pay-for-performance to cut costs. Health Aff. 2012;31(9):2051–8.CrossRefGoogle Scholar
  6. 6.
    Augustine JJ, Hricik DE. Anemia after kidney transplantation: time for action. J Am Soc Nephrol (JASN). 2006;17(11):2962–3.CrossRefGoogle Scholar
  7. 7.
    Mix TC, Kazmi W, Khan S, Ruthazer R, Rohrer R, Pereira BJ, et al. Anemia: a continuing problem following kidney transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2003;3(11):1426–33.CrossRefGoogle Scholar
  8. 8.
    Chhabra D, Grafals M, Skaro AI, Parker M, Gallon L. Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection. Clin J Am Soc Nephrol (CJASN). 2008;3(4):1168–74.CrossRefGoogle Scholar
  9. 9.
    Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52.CrossRefGoogle Scholar
  10. 10.
    Di Angelantonio E, Chowdhury R, Sarwar N, Aspelund T, Danesh J, Gudnason V. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ. 2010;341:c4986.CrossRefGoogle Scholar
  11. 11.
    Wang AY, Lam CW, Chan IH, Wang M, Lui SF, Sanderson JE. Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis. Hypertension. 2010;56(2):210–6.CrossRefGoogle Scholar
  12. 12.
    Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis. 1998;32(5):853–906.CrossRefGoogle Scholar
  13. 13.
    Ritz E, Wanner C. The challenge of sudden death in dialysis patients. Clin J Am Soc Nephrol (CJASN). 2008;3(3):920–9.CrossRefGoogle Scholar
  14. 14.
    Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725–30.CrossRefGoogle Scholar
  15. 15.
    Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis. 2000;35(4 Suppl 1):S117–31.CrossRefGoogle Scholar
  16. 16.
    Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112–9.CrossRefGoogle Scholar
  17. 17.
    Shirali AC, Bia MJ. Management of cardiovascular disease in renal transplant recipients. Clin J Am Soc Nephrol (CJASN). 2008;3(2):491–504.CrossRefGoogle Scholar
  18. 18.
    Kasiske B, Cosio FG, Beto J, Bolton K, Chavers BM, Grimm R Jr, et al. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2004;4(Suppl 7):13–53.CrossRefGoogle Scholar
  19. 19.
    Miller LW. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2002;2(9):807–18.CrossRefGoogle Scholar
  20. 20.
    van Hooff JP, Squifflet JP, Wlodarczyk Z, Vanrenterghem Y, Paczek L. A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients. Transplantation. 2003;75(12):1934–9.CrossRefGoogle Scholar
  21. 21.
    Vincenti F, Jensik SC, Filo RS, Miller J, Pirsch J. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation. 2002;73(5):775–82.CrossRefGoogle Scholar
  22. 22.
    Vanrenterghem Y, Bresnahan B, Campistol J, Durrbach A, Grinyo J, Neumayer HH, et al. Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies). Transplantation. 2011;91(9):976–83.CrossRefGoogle Scholar
  23. 23.
    Bonny O, Rubin A, Huang CL, Frawley WH, Pak CY, Moe OW. Mechanism of urinary calcium regulation by urinary magnesium and pH. J Am Soc Nephrol (JASN). 2008;19(8):1530–7.CrossRefGoogle Scholar
  24. 24.
    Schlieper G, Kruger T, Djuric Z, Damjanovic T, Markovic N, Schurgers LJ, et al. Vascular access calcification predicts mortality in hemodialysis patients. Kidney Int. 2008;74(12):1582–7.CrossRefGoogle Scholar
  25. 25.
    Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38(4):938–42.CrossRefGoogle Scholar
  26. 26.
    Hernandez D, Rufino M, Bartolomei S, Gonzalez-Rinne A, Lorenzo V, Cobo M, et al. Clinical impact of preexisting vascular calcifications on mortality after renal transplantation. Kidney Int. 2005;67(5):2015–20.CrossRefGoogle Scholar
  27. 27.
    Moe SM, Chen NX. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol (JASN). 2008;19(2):213–6.CrossRefGoogle Scholar
  28. 28.
    Oschatz E, Benesch T, Kodras K, Hoffmann U, Haas M. Changes of coronary calcification after kidney transplantation. Am J Kidney Dis. 2006;48(2):307–13.CrossRefGoogle Scholar
  29. 29.
    Priyadarshini P, Aggarwal S, Guleria S, Sharma S, Gulati GS. Short-term effects of renal transplantation on coronary artery calcification: a prospective study. Saudi J Kidney Dis Transpl. 2015;26(3):536–43.CrossRefGoogle Scholar
  30. 30.
    Bargnoux AS, Dupuy AM, Garrigue V, Jaussent I, Gahide G, Badiou S, et al. Evolution of coronary artery calcifications following kidney transplantation: relationship with osteoprotegerin levels. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2009;9(11):2571–9.CrossRefGoogle Scholar
  31. 31.
    Joshi VD. Quality of life in end stage renal disease patients. World J Nephrol. 2014;3(4):308–16.CrossRefGoogle Scholar
  32. 32.
    Jhamb M, Weisbord SD, Steel JL, Unruh M. Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors. Am J Kidney Dis. 2008;52(2):353–65.CrossRefGoogle Scholar
  33. 33.
    Jaar BG, Chang A, Plantinga L. Can we improve quality of life of patients on dialysis? Clin J Am Soc Nephrol (CJASN). 2013;8(1):1–4.CrossRefGoogle Scholar
  34. 34.
    Elder SJ, Pisoni RL, Akizawa T, Fissell R, Andreucci VE, Fukuhara S, et al. Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2008;23(3):998–1004.CrossRefGoogle Scholar
  35. 35.
    Abdel-Kader K, Myaskovsky L, Karpov I, Shah J, Hess R, Dew MA, et al. Individual quality of life in chronic kidney disease: influence of age and dialysis modality. Clin J Am Soc Nephrol (CJASN). 2009;4(4):711–8.CrossRefGoogle Scholar
  36. 36.
    Palmer SC, de Berardis G, Craig JC, Tong A, Tonelli M, Pellegrini F, et al. Patient satisfaction with in-centre haemodialysis care: an international survey. BMJ Open. 2014;4(5):e005020.CrossRefGoogle Scholar
  37. 37.
    Fiebiger W, Mitterbauer C, Oberbauer R. Health-related quality of life outcomes after kidney transplantation. Health Qual Life Outcomes. 2004;2:2.CrossRefGoogle Scholar
  38. 38.
    Aasebo W, Homb-Vesteraas NA, Hartmann A, Stavem K. Life situation and quality of life in young adult kidney transplant recipients. Nephrol Dial Transplant. 2009;24(1):304–8.CrossRefGoogle Scholar
  39. 39.
    Parajuli S, Sandal S, Liebman SE, Demme RA. Self-reported employment status and social participation after successful kidney transplantation. Prog Transplant. 2016;26(1):92–8.CrossRefGoogle Scholar
  40. 40.
    USRDS. Chapter 6: Medicare Expenditures for Persons With CKD. 2015.Google Scholar
  41. 41.
    USRDS. Chapter 11: Medicare Expenditures for Persons With ESRD. 2015.Google Scholar
  42. 42.
    Kerr M, Bray B, Medcalf J, O’Donoghue DJ, Matthews B. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant. 2012;27(Suppl 3):iii73–80.CrossRefGoogle Scholar
  43. 43.
  44. 44.
    Dalrymple LS, Go AS. Epidemiology of acute infections among patients with chronic kidney disease. Clin J Am Soc Nephrol (CJASN). 2008;3(5):1487–93.CrossRefGoogle Scholar
  45. 45.
    Foley RN, Wang C, Collins AJ. Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study. Mayo Clin Proc. 2005;80(10):1270–7.CrossRefGoogle Scholar
  46. 46.
    Allon M, Depner TA, Radeva M, Bailey J, Beddhu S, Butterly D, et al. Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. J Am Soc Nephrol (JASN). 2003;14(7):1863–70.CrossRefGoogle Scholar
  47. 47.
    Karuthu S, Blumberg EA. Common infections in kidney transplant recipients. Clin J Am Soc Nephrol (CJASN). 2012;7(12):2058–70.CrossRefGoogle Scholar
  48. 48.
    Cukuranovic J, Ugrenovic S, Jovanovic I, Visnjic M, Stefanovic V. Viral infection in renal transplant recipients. TheScientificWorldJOURNAL. 2012;2012:820621.CrossRefGoogle Scholar
  49. 49.
    Stengel B. Chronic kidney disease and cancer: a troubling connection. J Nephrol. 2010;23(3):253–62.PubMedPubMedCentralGoogle Scholar
  50. 50.
    Russo P. End stage and chronic kidney disease: associations with renal cancer. Front Oncol. 2012;2:28.CrossRefGoogle Scholar
  51. 51.
    Weng PH, Hung KY, Huang HL, Chen JH, Sung PK, Huang KC. Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol (CJASN). 2011;6(5):1121–8.CrossRefGoogle Scholar
  52. 52.
    Jorgensen L, Heuch I, Jenssen T, Jacobsen BK. Association of albuminuria and cancer incidence. J Am Soc Nephrol (JASN). 2008;19(5):992–8.CrossRefGoogle Scholar
  53. 53.
    Morath C, Mueller M, Goldschmidt H, Schwenger V, Opelz G, Zeier M. Malignancy in renal transplantation. J Am Soc Nephrol (JASN). 2004;15(6):1582–8.CrossRefGoogle Scholar
  54. 54.
    Flechner SM. Cancer and renal transplantation Johns hopkins Advaced Studies in Medicine 2007. Adv Stud Med. 2007;7(13):411–9.Google Scholar
  55. 55.
    Chapman JR, Webster AC, Wong G. Cancer in the transplant recipient. Cold Spring Harb Perspect Med. 2013;3(7):a015677.CrossRefGoogle Scholar
  56. 56.
    Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation. 2005;80(2 Suppl):S254–64.CrossRefGoogle Scholar
  57. 57.
    Stallone G, Infante B, Grandaliano G. Management and prevention of post-transplant malignancies in kidney transplant recipients. Clin Kidney J. 2015;8(5):637–44.CrossRefGoogle Scholar
  58. 58.
    Pita-Fernandez S, Valdes-Canedo F, Pertega-Diaz S, Seoane-Pillado MT, Seijo-Bestilleiro R. Cancer incidence in kidney transplant recipients: a study protocol. BMC Cancer. 2009;9:294.CrossRefGoogle Scholar
  59. 59.
    Sood P, Zhu YR, Cohen EP. Death with functioning kidney transplant: an obituarial analysis. Int Urol Nephrol. 2010;42(4):929–34.CrossRefGoogle Scholar
  60. 60.
    Marcen R, Teruel JL. Patient outcomes after kidney allograft loss. Transplant Rev. 2008;22(1):62–72.CrossRefGoogle Scholar
  61. 61.
    Karthikeyan V, Karpinski J, Nair RC, Knoll G. The burden of chronic kidney disease in renal transplant recipients. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2004;4(2):262–9.CrossRefGoogle Scholar
  62. 62.
    Marcen R, Pascual J, Tenorio M, Ocana EJ, Teruel JL, Villafruela JJ, et al. Chronic kidney disease in renal transplant recipients. Transplant Proc. 2005;37(9):3718–20.CrossRefGoogle Scholar
  63. 63.
    Al-Aly Z, Zeringue A, Fu J, Rauchman MI, McDonald JR, El-Achkar TM, et al. Rate of kidney function decline associates with mortality. J Am Soc Nephrol (JASN). 2010;21(11):1961–9.CrossRefGoogle Scholar
  64. 64.
    Djamali A, Kendziorski C, Brazy PC, Becker BN. Disease progression and outcomes in chronic kidney disease and renal transplantation. Kidney Int. 2003;64(5):1800–7.CrossRefGoogle Scholar
  65. 65.
    Kukla A, Adulla M, Pascual J, Samaniego M, Nanovic L, Becker BN, et al. CKD stage-to-stage progression in native and transplant kidney disease. Nephrol Dial Transplant. 2008;23(2):693–700.CrossRefGoogle Scholar
  66. 66.
    Velosa JA, Griffin MD, Larson TS, Gloor JM, Schwab TR, Sterioff S, et al. Can a transplanted living donor kidney function equivalently to its native partner? Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2002;2(3):252–9.CrossRefGoogle Scholar
  67. 67.
    Jimenez Alvaro S, Marcen R, Teruel JL, Fernandez Rodriguez A, Pascual J, Galeano C, et al. Management of chronic kidney disease after renal transplantation: is it different from nontransplant patients? Transplant Proc. 2009;41(6):2409–11.CrossRefGoogle Scholar
  68. 68.
    Marcen R, del Castillo D, Capdevila L, Fernandez-Fresnedo G, Rodrigo E, Cantarell C, et al. Achieving chronic kidney disease treatment targets in renal transplant recipients: results from a cross-sectional study in Spain. Transplantation. 2009;87(9):1340–6.CrossRefGoogle Scholar
  69. 69.
    Ansell D, Udayaraj UP, Steenkamp R, Dudley CR. Chronic renal failure in kidney transplant recipients. Do they receive optimum care?: data from the UK renal registry. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2007;7(5):1167–76.CrossRefGoogle Scholar
  70. 70.
    Montanaro D, Gropuzzo M, Tulissi P, Boscutti G, Risaliti A, Baccarani U, et al. Cardiovascular disease after renal transplantation. Giornale italiano di nefrologia: organo ufficiale della Societa italiana di nefrologia. 2004;21(Suppl 26):S53–66.Google Scholar
  71. 71.
    Forsythe JL. Graft function and other risk factors as predictors of cardiovascular disease outcome. Transplantation. 2001;72(6 Suppl):S16–9.CrossRefGoogle Scholar
  72. 72.
    Perl J, Bargman JM, Davies SJ, Jassal SV. Clinical outcomes after failed renal transplantation-does dialysis modality matter? Semin Dial. 2008;21(3):239–44.CrossRefGoogle Scholar
  73. 73.
    Kaplan B, Meier-Kriesche HU. Death after graft loss: an important late study endpoint in kidney transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2002;2(10):970–4.CrossRefGoogle Scholar
  74. 74.
    Harambat J, Cochat P. Growth after renal transplantation. Pediatr Nephrol. 2009;24(7):1297–306.CrossRefGoogle Scholar
  75. 75.
    McKay DB, Josephson MA. Pregnancy after kidney transplantation. Clin J Am Soc Nephrol (CJASN). 2008;3(Suppl 2):S117–25.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Medicine, Division of NephrologyUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA
  2. 2.Department of MedicineBaylor College of MedicineHoustonUSA

Personalised recommendations